NCT00299676View on ClinicalTrials.gov

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Alzheimer DiseaseDementiaGalantamine

Interventions

DRUG

Galantamine (Reminyl)

Use of Reminyl according to approved NZ data sheet

Trial Locations (5)

Unknown

Auckland

Christchurch Nz

Hamilton

Porirua

Tauranga

All Listed Sponsors

lead

Janssen-Cilag Pty Ltd

INDUSTRY

NCT00299676 - An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period | Biotech Hunter | Biotech Hunter